Patents by Inventor Serge Adnot

Serge Adnot has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTION OR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
    Publication number: 20150126573
    Abstract: The present invention relates to methods and compositions for the prevention or treatment of chronic obstructive pulmonary disease.
    Type: Application
    Filed: May 7, 2013
    Publication date: May 7, 2015
    Inventors: Jorge Bernardo Boczkowski, Serge Adnot, Maylis Dagouassat, Jean-Marie Gagliolo
  • NUTLIN COMPOUNDS FOR USE IN THE TREATMENT OF PULMONARY HYPERTENSION
    Publication number: 20140328893
    Abstract: The present invention relates to uses, methods and compositions for the treatment of pulmonary hypertension.
    Type: Application
    Filed: October 11, 2011
    Publication date: November 6, 2014
    Applicant: Institut National de la Sante et de la Recherche Medicale (INSERM)
    Inventor: Serge Adnot
  • METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF PULMONARY HYPERTENSION
    Publication number: 20140271680
    Abstract: The present invention relates to uses, methods and compositions for the treatment of pulmonary hypertension.
    Type: Application
    Filed: August 10, 2012
    Publication date: September 18, 2014
    Applicant: UNIVERSITE PARIS-EST CRETEIL VAL DE MARNE
    Inventors: Serge Adnot, Valerie Amsellem
  • Roflumilast for the treatment of pulmonary hypertension
    Patent number: 8648100
    Abstract: The invention relates to the use of Roflumilast, Roflumilast N-Oxide or a pharmaceutically acceptable salt of either for the treatment of pulmonary hypertension. The invention additionally relates to the use of Roflumilast, Roflumilast N-oxide or a pharmaceutically acceptable salt of either in combination with a PDE5 inhibitor or a pharmaceutically acceptable salt thereof for the treatment of pulmonary hypertension.
    Type: Grant
    Filed: April 12, 2006
    Date of Patent: February 11, 2014
    Assignee: Takeda GmbH
    Inventors: Rolf Beume, Armin Hatzelmann, Degenhard Marx, Christian Schudt, Hermann Tenor, Saadia Eddahibi, Serge Adnot
  • Methods for preventing, attenuating or treating pulmonary hypertension using a serotonin transporter inhibitor, and pharmaceutical compositions for the treatment thereof
    Patent number: 8614247
    Abstract: The invention relates to a method for preventing, attenuating or treating pulmonary hypertension in an individual in need thereof, comprising administering at least one 5-HTT inhibitor to said individual.
    Type: Grant
    Filed: October 11, 2005
    Date of Patent: December 24, 2013
    Assignees: Institut National de la Sante et de la Recherche Medicale, Assistance Publique-Hopitaux de Paris
    Inventors: Serge Adnot, Saadla Eddahibi
  • Roflumilast for the Treatment of Pulmonary Hypertension
    Publication number: 20090215836
    Abstract: The invention relates to the use of Roflumilast, Roflumilast N-Oxide or a pharmaceutically acceptable salt of either for the treatment of pulmonary hypertension. The invention additionally relates to the use of Roflumilast, Roflumilast N-oxide or a pharmaceutically acceptable salt of either in combination with a PDE5 inhibitor or a pharmaceutically acceptable salt thereof for the treatment of pulmonary hypertension.
    Type: Application
    Filed: April 12, 2006
    Publication date: August 27, 2009
    Applicant: NYCOMED GMBH
    Inventors: Rolf Beume, Armin Hatzelmann, Degenhard Marx, Christian Schudt, Hermann Tenor, Saadia Eddahibi, Serge Adnot
  • Methods for preventing, attenuating or treating pulmonary hypertension using a serotonin transporter inhibitor, and pharmaceutical compositions for the treatment thereof
    Publication number: 20060100270
    Abstract: The invention relates to a method for preventing, attenuating or treating pulmonary hypertension in an individual in need thereof, comprising administering at least one 5-HTT inhibitor to said individual.
    Type: Application
    Filed: October 11, 2005
    Publication date: May 11, 2006
    Applicants: Assistance Publique-Hopitaux De Paris, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
    Inventors: Serge Adnot, Saadla Eddahibi
  • Use of a defective recombinant adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension
    Publication number: 20020086004
    Abstract: The present invention relates to the use of a vector which comprises a nucleic acid encoding an angiogenic factor for preventing, ameliorating or treating pulmonary hypertension. It also relates to specific pharmaceutical compositions which enable these vectors to be administered locally and efficiently.
    Type: Application
    Filed: October 26, 2001
    Publication date: July 4, 2002
    Inventors: Serge Adnot, Didier Branellec